- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ovarian, fallopian tube or primary peritoneal cancer
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1722KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 235KB)
Olaparib – July 2020
Olaparib: Tablet 100 mg, Tablet 150 mg: Lynparza®
Last updated
30 October 2020